Brind.

MicroGenDX incorporated Illumina's MiSeq platform to deliver leading-edge NGS testing, quickly identifying C. acnes.

1 report, 1 independent Updated Sep 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Illumina CAP

Keep exploring

The entities involved

Illumina
American company that develops systems for the analysis of genetic variation
- Analysis suggests that both Moderna and Illumina stocks are currently overvalued.Wed 13:01
CAP
- ICMSA is pushing for stricter qualification rules regarding CAP subsidies.Sun 08:36
- Peace talks regarding Ukraine's EU accession are underway, but progress is stalled by minority rights issues, future EU budget strains, and concerns over the Common Agricultural Policy (CAP).Fri 09:37

Coverage

Newest first; wire copies grouped

Sep 2ACCESS NewswireMicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions Adoption of Illumina's MiSeq i100 Plus accelerates results delivery to next-day from sample receipt, s